Second Clinical Trial Getting Underway for PathMaker’s Non-Invasive ALS Treatment PlatformBOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- (“PathMaker”), a clinical-stage neuromodulation company developing ...

Victory Capital Holdings Limited ( NASDAQ: VCTR) Q4 2024 Earnings Conference Call February 7, 2025 8:00 AM ET David Brown - Chairman, Chief Executive Officer Michael Pilicarpo - President, Chief ...

Operator: Good morning and welcome to the Zurn Elkay Water Solutions Corporation Fourth Quarter 2024 Earnings Results Conference Call with Todd Adams, Chairman and Chief Executive Officer; David ...

Tradeweb Markets Inc. ( NASDAQ: TW) Q4 2024 Earnings Conference Call February 6, 2025 9:30 AM ET Ashley Serrao - Head of Treasury, FP&A, and IR Billy Hult - CEO Sara Furber - CFO ...

By the end of 2024, the US Food and Drug Administration (FDA) is expected to formally make reviews by a single institutional review board (sIRB) the standard for most multisite, regulated clinical ...

This study presents a useful finding that targeting amino acid metabolism can overcome Trastuzumab resistance in HER2+ breast cancer. The evidence supporting the claims of the authors is solid and the ...

Robert Weilminster; EVP, Investor Relations; Magnera Corp. Curt Begle; Chief Executive Officer; Magnera Corp. Jim Till; Chief Financial Officer & Treasurer; Magnera ...

Researchers found that moderate triclosan exposure is significantly linked to increased breast cancer risk, particularly in ...

A Moody's Ratings upgrade means Hawaii DOT's airport division is headed to market with across-the-board double-A ratings.

Days before Seattle-area residents planned to commemorate the 88 lives lost on Alaska Airlines Flight 261, another collision ...

Find all the latest Q3 results 2025 updates for Reliance Communications, State Bank of India SBI, Hero MotoCorp, ITC, MRF, ...

Trump suffers another big defeat as judge blocks federal worker buyout; president plots Christian task force: Live - ...